Centauri Therapeutics

Company type

Chromatin Bioscience

Meet Chromatin Bioscience at the UK Pavilion, booth 38.
By mining the genome using our bioinformatics platform we discover and re-purpose natural gene regulatory elements, creating customised gene expression systems to:

Improve human health

Creating highly selective and controllable promoters and gene expression cassettes for novel gene and cell therapy systems

Improving the efficiency of b iologics production by increasing protein yields in upstream manufacturing processes

Engineer biology

Harnessing synthetic biology by making promoters for the wide array of chassis organisms used in Industrial Biotech

Creating switches and gene circuits to be employed in any metabolic engineering application

Enable traits discovery

Designing tissue-selective plant synthetic promoters active across  different crop species for Agricultural Biotech applications

Using plant genomics to facilitate the design of environmentally-regulated and pathogen-responsive promoters

Website:
chromatinbio.com
Company type
Dr Konstantinos Drosopoulos
Director of Business Development